先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2018, vol.10, no.1 2018, vol.10, no.2 2018, vol.10, no.3 2018, vol.10, no.4 2018, vol.10, no.5 2018, vol.10, no.6
2018, vol.10, no.7 2018, vol.10, no.8

题名作者出版年年卷期
Comprehensive study of domain rearrangements of single-chain bispecific antibodies to determine the best combination of configurations and microbial host cellsRyutaro Asano;Yuri Kuroki;Sachiko Honma;Mihoko Akabane;Shunsuke Watanabe;Shinzo Mayuzumi;Shuichi Hiyamuta;Izumi Kumagai;Koji Sode;20182018, vol.10, no.6
Antibody pharmacokinetics in rat brain determined using microdialysisHsueh-Yuan Chang;Kasey Morrow;Emily Bonacquisti;WanYing Zhang;Dhaval K. Shah;20182018, vol.10, no.6
Antigen recognition by single-domain antibodies: structural latitudes and constraintsKevin A. Henry;C. Roger MacKenzie;20182018, vol.10, no.6
Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin AmericaMorton Scheinberg;Carlos Pineda;Gilberto Castañeda-Hernández;Juan José Zarbá;Aderson Damião;Luiz H Arantes Jr;Ira Jacobs;20182018, vol.10, no.6
Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agentsXiling Jiang;Xi Chen;Thomas J. Carpenter;Jun Wang;Rebecca Zhou;Hugh M. Davis;Donald L. Heald;Weirong Wang;20182018, vol.10, no.6
Structure Based Prediction of Asparagine Deamidation Propensity in Monoclonal AntibodiesQingrong Yan;Maggie Huang;Michael J. Lewis;Ping Hu;20182018, vol.10, no.6
Heterologous recombinant expression of non-originator NISTmAbLila Kashi;Katharina Yandrofski;Renae J. Preston;Luke W. Arbogast;John P. Giddens;John P. Marino;John E. Schiel;Zvi Kelman;20182018, vol.10, no.6
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trialWon Park;Ljubinka Božić-Majstorović;Dragana Milakovic;Alfredo Berrocal Kasay;Elias Chalouhi El-Khouri;Fedra Irazoque-Palazuelos;Francisco Fidencio Cons Molina;Pavel Shesternya;Pedro Miranda;Francisco G. Medina-Rodriguez;Piotr Wiland;Slawomir Jeka;Jose Chavez-Corrales;Olena Garmish;Thomas Linde;Dmytro Rekalov;Pawel Hrycaj;Andreas Krause;Natalia Fomina;Olena Piura;Mauricio Abello-Banfi;Chang-Hee Suh;Seung Cheol Shim;Sang Joon Lee;Sung Young Lee;Sung Hwan Kim;Dae Hyun Yoo;20182018, vol.10, no.6
FcγRIIIa-dependent IFN-γ release in whole blood assay is predictive of therapeutic IgG1 antibodies safetyNada S. Alakhras;Jiabin Qiu;Guilherme V. Rocha;Derrick R. Witcher;Anja Koester;Jinsam You;David A. Schaer;Rikke B. Holmgaard;Kyla Driscoll;Jeffrey A. Willy;Laurent P. Malherbe;20182018, vol.10, no.6
Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodiesArif Jetha;Nels Thorsteinson;Yazen Jmeian;Ajitha Jeganathan;Patricia Giblin;Johan Fransson;20182018, vol.10, no.6
12